A detailed history of Strong Tower Advisory Services transactions in Novo Nordisk A S stock. As of the latest transaction made, Strong Tower Advisory Services holds 23,524 shares of NVO stock, worth $2.59 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
23,524
Previous 25,160 6.5%
Holding current value
$2.59 Million
Previous $3.59 Million 22.0%
% of portfolio
0.81%
Previous 1.22%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$119.07 - $145.42 $194,798 - $237,907
-1,636 Reduced 6.5%
23,524 $2.8 Million
Q2 2024

Jul 15, 2024

BUY
$122.71 - $146.91 $293,890 - $351,849
2,395 Added 10.52%
25,160 $3.59 Million
Q1 2024

Apr 12, 2024

BUY
$102.11 - $135.92 $67,086 - $89,299
657 Added 2.97%
22,765 $2.92 Million
Q4 2023

Jan 18, 2024

BUY
$87.78 - $105.45 $23,437 - $28,155
267 Added 1.22%
22,108 $2.29 Million
Q3 2023

Oct 10, 2023

BUY
$90.94 - $199.54 $999,248 - $2.19 Million
10,988 Added 101.24%
21,841 $1.99 Million
Q2 2023

Jul 13, 2023

SELL
$155.98 - $172.65 $71,126 - $78,728
-456 Reduced 4.03%
10,853 $1.76 Million
Q1 2023

Apr 14, 2023

SELL
$132.34 - $159.14 $41,951 - $50,447
-317 Reduced 2.73%
11,309 $1.8 Million
Q4 2022

Jan 20, 2023

BUY
$102.55 - $135.33 $5,640 - $7,443
55 Added 0.48%
11,626 $0
Q3 2022

Oct 14, 2022

BUY
$95.28 - $116.93 $15,625 - $19,176
164 Added 1.44%
11,571 $1.15 Million
Q2 2022

Aug 10, 2022

SELL
$103.24 - $121.81 $31,384 - $37,030
-304 Reduced 2.6%
11,407 $1.27 Million
Q1 2022

Apr 14, 2022

BUY
$93.1 - $112.54 $66,473 - $80,353
714 Added 6.49%
11,711 $1.3 Million
Q4 2021

Jan 18, 2022

SELL
$95.88 - $117.08 $30,777 - $37,582
-321 Reduced 2.84%
10,997 $1.23 Million
Q3 2021

Oct 29, 2021

BUY
$84.42 - $106.62 $955,465 - $1.21 Million
11,318 New
11,318 $1.14 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $249B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Strong Tower Advisory Services Portfolio

Follow Strong Tower Advisory Services and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strong Tower Advisory Services, based on Form 13F filings with the SEC.

News

Stay updated on Strong Tower Advisory Services with notifications on news.